<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:75b0e15c-a85c-466d-8d99-1ddac5345606,g:434e5c86-19a4-4058-8bc2-831f0bbf9371-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.connectbiopharm.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="cntb-20250630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.connectbiopharm.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_98bf1950-5232-4208-8d50-d40781f60d90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4ecf4316-736f-4db2-8c83-ecc2cec4c649" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_98bf1950-5232-4208-8d50-d40781f60d90" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4ecf4316-736f-4db2-8c83-ecc2cec4c649" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_60e3e07e-7f50-4d71-8362-2abf55e6983c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_98bf1950-5232-4208-8d50-d40781f60d90" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_60e3e07e-7f50-4d71-8362-2abf55e6983c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_62c8f490-466f-475e-a614-f6e283c913be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_98bf1950-5232-4208-8d50-d40781f60d90" xlink:to="loc_us-gaap_CommonStockValue_62c8f490-466f-475e-a614-f6e283c913be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_1145a38e-0fda-426a-9bbf-51402408b3ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_98bf1950-5232-4208-8d50-d40781f60d90" xlink:to="loc_us-gaap_AdditionalPaidInCapital_1145a38e-0fda-426a-9bbf-51402408b3ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_0ee535ca-3aae-49e2-9149-3f0badc3ad96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_98bf1950-5232-4208-8d50-d40781f60d90" xlink:to="loc_us-gaap_TreasuryStockCommonValue_0ee535ca-3aae-49e2-9149-3f0badc3ad96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_cbab549e-ed32-4e0d-a7c4-8a9f480aeec0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4073031e-0a75-47ef-8923-ff95460e3d23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cbab549e-ed32-4e0d-a7c4-8a9f480aeec0" xlink:to="loc_us-gaap_Liabilities_4073031e-0a75-47ef-8923-ff95460e3d23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_5b86071f-d5f6-4f9c-b0ea-57a3d98db3f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cbab549e-ed32-4e0d-a7c4-8a9f480aeec0" xlink:to="loc_us-gaap_CommitmentsAndContingencies_5b86071f-d5f6-4f9c-b0ea-57a3d98db3f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e26ef493-183d-488a-8b84-c64e65aa3e84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cbab549e-ed32-4e0d-a7c4-8a9f480aeec0" xlink:to="loc_us-gaap_StockholdersEquity_e26ef493-183d-488a-8b84-c64e65aa3e84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f15b4037-22cd-4973-b06c-08f09a95a57d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_736b58c0-c8ea-4b06-afc3-f935c6688a41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f15b4037-22cd-4973-b06c-08f09a95a57d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_736b58c0-c8ea-4b06-afc3-f935c6688a41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3d848c5d-a08b-4c74-9350-14341da6b80e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f15b4037-22cd-4973-b06c-08f09a95a57d" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_3d848c5d-a08b-4c74-9350-14341da6b80e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_756a8fd4-d685-4bba-96fe-6c1e0fa39e33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f15b4037-22cd-4973-b06c-08f09a95a57d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_756a8fd4-d685-4bba-96fe-6c1e0fa39e33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_18ec19f2-c06f-479d-9528-3f026602daeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f15b4037-22cd-4973-b06c-08f09a95a57d" xlink:to="loc_us-gaap_AccountsPayableCurrent_18ec19f2-c06f-479d-9528-3f026602daeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_022d1341-5185-4960-94db-60478920ce56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_86f174e1-871f-4dfd-9287-0c0ccf3ae66f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_022d1341-5185-4960-94db-60478920ce56" xlink:to="loc_us-gaap_ShortTermInvestments_86f174e1-871f-4dfd-9287-0c0ccf3ae66f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_542b06b9-d870-49b3-9012-4cc305c051f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_022d1341-5185-4960-94db-60478920ce56" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_542b06b9-d870-49b3-9012-4cc305c051f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1a1b10e6-96ad-4321-bf24-dbda39a1c9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_022d1341-5185-4960-94db-60478920ce56" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1a1b10e6-96ad-4321-bf24-dbda39a1c9f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_138c04ed-2244-4c12-89b1-daa102098760" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_022d1341-5185-4960-94db-60478920ce56" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_138c04ed-2244-4c12-89b1-daa102098760" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_31f01965-eceb-4495-bf3e-18b2f504e6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b2651fed-cf02-4b43-8537-444dd0ae34a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_31f01965-eceb-4495-bf3e-18b2f504e6f9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b2651fed-cf02-4b43-8537-444dd0ae34a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1d9f850e-a2d9-4d9d-a3c4-725a06c36d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_31f01965-eceb-4495-bf3e-18b2f504e6f9" xlink:to="loc_us-gaap_LiabilitiesCurrent_1d9f850e-a2d9-4d9d-a3c4-725a06c36d8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1dc37f76-2eb1-4799-b833-8e27ea7a19b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_31f01965-eceb-4495-bf3e-18b2f504e6f9" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1dc37f76-2eb1-4799-b833-8e27ea7a19b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ace9092b-f558-4926-94f8-9bb5190dda51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9eba5a2e-8df2-4e64-94b6-1f09f3f34db7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ace9092b-f558-4926-94f8-9bb5190dda51" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9eba5a2e-8df2-4e64-94b6-1f09f3f34db7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8c0502e3-f460-4537-be56-c9f56cbdf851" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ace9092b-f558-4926-94f8-9bb5190dda51" xlink:to="loc_us-gaap_AssetsCurrent_8c0502e3-f460-4537-be56-c9f56cbdf851" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cd39886d-6a9d-49a8-ad3d-69bea4c4277c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ace9092b-f558-4926-94f8-9bb5190dda51" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cd39886d-6a9d-49a8-ad3d-69bea4c4277c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_78d711b2-65fa-4e8f-8e5b-d72aa87ff8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ace9092b-f558-4926-94f8-9bb5190dda51" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_78d711b2-65fa-4e8f-8e5b-d72aa87ff8bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_67678ecd-7f4d-428d-ba48-808cccd1bc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ace9092b-f558-4926-94f8-9bb5190dda51" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_67678ecd-7f4d-428d-ba48-808cccd1bc0b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.connectbiopharm.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="cntb-20250630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.connectbiopharm.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a623a419-0fae-4512-881e-02b4ce235d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5b967e9f-455b-4512-a50a-5af77a2656c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a623a419-0fae-4512-881e-02b4ce235d1e" xlink:to="loc_us-gaap_NetIncomeLoss_5b967e9f-455b-4512-a50a-5af77a2656c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0431839b-af0a-4a34-9a8a-92a8fb120f29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a623a419-0fae-4512-881e-02b4ce235d1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0431839b-af0a-4a34-9a8a-92a8fb120f29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f2ee25e9-3352-4e78-bc6d-e19b5979b40f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a623a419-0fae-4512-881e-02b4ce235d1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f2ee25e9-3352-4e78-bc6d-e19b5979b40f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_5df856b0-7753-4654-8077-443ce291e2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_4ef42194-7c30-449d-8087-f6ddee273371" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_5df856b0-7753-4654-8077-443ce291e2fe" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_4ef42194-7c30-449d-8087-f6ddee273371" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2d05c8c1-e273-4539-8d8a-2e6ce2f50029" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_5df856b0-7753-4654-8077-443ce291e2fe" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2d05c8c1-e273-4539-8d8a-2e6ce2f50029" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7ae3f334-3c60-4e64-8006-c1d062b58b84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9c93e96f-4de9-4931-b228-92ae5937d5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7ae3f334-3c60-4e64-8006-c1d062b58b84" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9c93e96f-4de9-4931-b228-92ae5937d5ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_971de2f0-2bb3-4771-acd0-3a52ab39c867" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7ae3f334-3c60-4e64-8006-c1d062b58b84" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_971de2f0-2bb3-4771-acd0-3a52ab39c867" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_ca04a5f6-dd19-46f0-b496-abc258c4ac94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_ff2d2491-c809-4f2f-b957-3b102947c4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_ca04a5f6-dd19-46f0-b496-abc258c4ac94" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_ff2d2491-c809-4f2f-b957-3b102947c4e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d9426176-5443-48f0-8659-f33c7e665f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_ca04a5f6-dd19-46f0-b496-abc258c4ac94" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d9426176-5443-48f0-8659-f33c7e665f7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7275a6d1-dbb2-440b-a4c8-f22a85c10595" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_097c9e19-05a4-42a5-baca-93ea39520042" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7275a6d1-dbb2-440b-a4c8-f22a85c10595" xlink:to="loc_us-gaap_OperatingExpenses_097c9e19-05a4-42a5-baca-93ea39520042" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4e1c1589-0d51-4eb8-83fc-df50973f79a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7275a6d1-dbb2-440b-a4c8-f22a85c10595" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4e1c1589-0d51-4eb8-83fc-df50973f79a2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.connectbiopharm.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="cntb-20250630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.connectbiopharm.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c6ba36b8-5b6a-4921-888c-773a0f483c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11371889-223b-4465-a7e3-265e280551c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c6ba36b8-5b6a-4921-888c-773a0f483c7c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11371889-223b-4465-a7e3-265e280551c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_51da7479-13a3-4941-ac26-b701dc47ca44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c6ba36b8-5b6a-4921-888c-773a0f483c7c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_51da7479-13a3-4941-ac26-b701dc47ca44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4e9cdd97-9142-4504-8b66-466174e9187c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c6ba36b8-5b6a-4921-888c-773a0f483c7c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4e9cdd97-9142-4504-8b66-466174e9187c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dc4e1047-d7b6-4415-91d8-8e8dfc188cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c6ba36b8-5b6a-4921-888c-773a0f483c7c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dc4e1047-d7b6-4415-91d8-8e8dfc188cc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06909f66-c706-40bb-bc3f-04c5a7d78005" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_70842474-3627-4f37-b91f-de039dcb05a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06909f66-c706-40bb-bc3f-04c5a7d78005" xlink:to="loc_us-gaap_NetIncomeLoss_70842474-3627-4f37-b91f-de039dcb05a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_f793df8e-9034-45bd-bc81-66307131e512" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06909f66-c706-40bb-bc3f-04c5a7d78005" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_f793df8e-9034-45bd-bc81-66307131e512" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_a2e37e03-3b86-4b65-bae0-bd3a952a55f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06909f66-c706-40bb-bc3f-04c5a7d78005" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_a2e37e03-3b86-4b65-bae0-bd3a952a55f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ee106886-5e28-4f29-925b-067b40d40138" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06909f66-c706-40bb-bc3f-04c5a7d78005" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ee106886-5e28-4f29-925b-067b40d40138" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_54219185-1914-438e-a992-5a690550c3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06909f66-c706-40bb-bc3f-04c5a7d78005" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_54219185-1914-438e-a992-5a690550c3d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cntb_IncreaseDecreaseInContractWithCustomerAssetCurrent_d6b61f50-2040-42c8-9e06-076d04cff1d8" xlink:href="cntb-20250630.xsd#cntb_IncreaseDecreaseInContractWithCustomerAssetCurrent"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06909f66-c706-40bb-bc3f-04c5a7d78005" xlink:to="loc_cntb_IncreaseDecreaseInContractWithCustomerAssetCurrent_d6b61f50-2040-42c8-9e06-076d04cff1d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_0b58c18e-824c-4ac7-ae69-9998f47f1223" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06909f66-c706-40bb-bc3f-04c5a7d78005" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_0b58c18e-824c-4ac7-ae69-9998f47f1223" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f0bc5a7a-9b08-4f8d-80c0-f300d4da3dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06909f66-c706-40bb-bc3f-04c5a7d78005" xlink:to="loc_us-gaap_ShareBasedCompensation_f0bc5a7a-9b08-4f8d-80c0-f300d4da3dd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9693319d-384a-4bf1-93a9-3a32ca21229f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06909f66-c706-40bb-bc3f-04c5a7d78005" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9693319d-384a-4bf1-93a9-3a32ca21229f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_28596310-af24-465c-a065-b0cd2310ea90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06909f66-c706-40bb-bc3f-04c5a7d78005" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_28596310-af24-465c-a065-b0cd2310ea90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6b47c501-a182-4bbf-a58b-691906e559dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06909f66-c706-40bb-bc3f-04c5a7d78005" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6b47c501-a182-4bbf-a58b-691906e559dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cntb_IncreaseDecreaseInContractWithCustomerLiabilityCurrent_f73b7d1d-1365-47e7-af5d-a5b2f7990ecd" xlink:href="cntb-20250630.xsd#cntb_IncreaseDecreaseInContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06909f66-c706-40bb-bc3f-04c5a7d78005" xlink:to="loc_cntb_IncreaseDecreaseInContractWithCustomerLiabilityCurrent_f73b7d1d-1365-47e7-af5d-a5b2f7990ecd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_e09d0aef-26c7-4eb2-9586-a777c26c226b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06909f66-c706-40bb-bc3f-04c5a7d78005" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_e09d0aef-26c7-4eb2-9586-a777c26c226b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_98258d6e-d32e-4b63-b453-6493d0a11c87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06909f66-c706-40bb-bc3f-04c5a7d78005" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_98258d6e-d32e-4b63-b453-6493d0a11c87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_06055290-6000-4637-8771-cc6798d2f834" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_2a6b0a58-5f19-47a7-bc9a-e0cae6bd0362" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_06055290-6000-4637-8771-cc6798d2f834" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_2a6b0a58-5f19-47a7-bc9a-e0cae6bd0362" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_69eda6a8-9596-4b00-ab99-d11f9c48fb27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_06055290-6000-4637-8771-cc6798d2f834" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_69eda6a8-9596-4b00-ab99-d11f9c48fb27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_00915331-5d66-40fd-8297-c7526e530b37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_06055290-6000-4637-8771-cc6798d2f834" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_00915331-5d66-40fd-8297-c7526e530b37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a9267bda-49d3-400f-802a-30aceeb31d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_06055290-6000-4637-8771-cc6798d2f834" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a9267bda-49d3-400f-802a-30aceeb31d8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4311083f-a30b-4d82-9369-e253405f3365" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_8f925743-4e7c-4a07-9cc8-9e4d8b0b4c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4311083f-a30b-4d82-9369-e253405f3365" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_8f925743-4e7c-4a07-9cc8-9e4d8b0b4c6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_c3340399-6782-4720-9fa5-fb2fedf49d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4311083f-a30b-4d82-9369-e253405f3365" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_c3340399-6782-4720-9fa5-fb2fedf49d1d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.connectbiopharm.com/role/BasisofPresentationandSignificantAccountingPoliciesScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="cntb-20250630.xsd#BasisofPresentationandSignificantAccountingPoliciesScheduleofEarningsPerShareBasicandDilutedDetails"/>
  <link:calculationLink xlink:role="http://www.connectbiopharm.com/role/BasisofPresentationandSignificantAccountingPoliciesScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f3822db8-f388-4d13-be74-081fb20e2d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6cba74ba-81d7-4f18-86d3-8c90f77a09ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f3822db8-f388-4d13-be74-081fb20e2d0e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6cba74ba-81d7-4f18-86d3-8c90f77a09ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_02435df9-ade7-41b5-a260-7e8644b4c77c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f3822db8-f388-4d13-be74-081fb20e2d0e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_02435df9-ade7-41b5-a260-7e8644b4c77c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.connectbiopharm.com/role/FairValueMeasurementsScheduleofCashCashEquivalentsandShortTermInvestmentsDetails" xlink:type="simple" xlink:href="cntb-20250630.xsd#FairValueMeasurementsScheduleofCashCashEquivalentsandShortTermInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.connectbiopharm.com/role/FairValueMeasurementsScheduleofCashCashEquivalentsandShortTermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_4eedea43-9a24-4dc4-9677-6e625dabfab9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_cntb_ShortTermInvestmentsFairValueDisclosure_9ed24b5a-46a3-4c49-bea6-786e91b8a5b1" xlink:href="cntb-20250630.xsd#cntb_ShortTermInvestmentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_4eedea43-9a24-4dc4-9677-6e625dabfab9" xlink:to="loc_cntb_ShortTermInvestmentsFairValueDisclosure_9ed24b5a-46a3-4c49-bea6-786e91b8a5b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4cb51c1a-aef3-4919-8138-9d898e977ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_4eedea43-9a24-4dc4-9677-6e625dabfab9" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4cb51c1a-aef3-4919-8138-9d898e977ed6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.connectbiopharm.com/role/BalanceSheetDetailsScheduleofAvailableforSaleInvestmentsDetails" xlink:type="simple" xlink:href="cntb-20250630.xsd#BalanceSheetDetailsScheduleofAvailableforSaleInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.connectbiopharm.com/role/BalanceSheetDetailsScheduleofAvailableforSaleInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_a3575f35-22bc-4e49-a19b-85c5eefc7d65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6559cdc7-3d3f-45fa-9b62-e49ae5c24bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_a3575f35-22bc-4e49-a19b-85c5eefc7d65" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6559cdc7-3d3f-45fa-9b62-e49ae5c24bb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_79e6ceea-4ac8-47b8-8fe5-daf668831438" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_a3575f35-22bc-4e49-a19b-85c5eefc7d65" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_79e6ceea-4ac8-47b8-8fe5-daf668831438" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_77cf90dc-d1a1-4ca8-9ea4-803c49afe411" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_a3575f35-22bc-4e49-a19b-85c5eefc7d65" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_77cf90dc-d1a1-4ca8-9ea4-803c49afe411" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.connectbiopharm.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="cntb-20250630.xsd#BalanceSheetDetailsScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.connectbiopharm.com/role/BalanceSheetDetailsScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c4f28052-47d9-46f7-97a6-635a6d883a08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_bb5c6ee1-13e3-4eec-b3e5-b61390ad8ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c4f28052-47d9-46f7-97a6-635a6d883a08" xlink:to="loc_us-gaap_OtherAssetsCurrent_bb5c6ee1-13e3-4eec-b3e5-b61390ad8ba4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_ce431d6e-eca5-4569-8661-6b7d69244922" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c4f28052-47d9-46f7-97a6-635a6d883a08" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_ce431d6e-eca5-4569-8661-6b7d69244922" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableCurrent_67b6450b-3292-4df6-a0ce-360ff5c26c66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestReceivableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c4f28052-47d9-46f7-97a6-635a6d883a08" xlink:to="loc_us-gaap_InterestReceivableCurrent_67b6450b-3292-4df6-a0ce-360ff5c26c66" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.connectbiopharm.com/role/BalanceSheetDetailsScheduleofAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="cntb-20250630.xsd#BalanceSheetDetailsScheduleofAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.connectbiopharm.com/role/BalanceSheetDetailsScheduleofAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6dfeecfa-5d3b-4b4d-b9fa-99d03ee2b496" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ccc7f5a6-94b5-4ca9-94d2-08e3a968012e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6dfeecfa-5d3b-4b4d-b9fa-99d03ee2b496" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ccc7f5a6-94b5-4ca9-94d2-08e3a968012e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cntb_AccruedClinicalManufacturingAndProfessionalExpenseCurrent_9a2d9c80-6528-4ced-8cbc-3c461d2157da" xlink:href="cntb-20250630.xsd#cntb_AccruedClinicalManufacturingAndProfessionalExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6dfeecfa-5d3b-4b4d-b9fa-99d03ee2b496" xlink:to="loc_cntb_AccruedClinicalManufacturingAndProfessionalExpenseCurrent_9a2d9c80-6528-4ced-8cbc-3c461d2157da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d9f678d9-47a4-4f60-9f7b-f69c81f0f33e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6dfeecfa-5d3b-4b4d-b9fa-99d03ee2b496" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d9f678d9-47a4-4f60-9f7b-f69c81f0f33e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.connectbiopharm.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="cntb-20250630.xsd#LeasesScheduleofFutureMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.connectbiopharm.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_623f86ef-6cc9-45ce-b1a4-425b79ff621a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0aeef6b1-83ef-4087-a21f-5d5845789b47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_623f86ef-6cc9-45ce-b1a4-425b79ff621a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0aeef6b1-83ef-4087-a21f-5d5845789b47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ae351fe7-dcf4-4d99-9dcd-b9b7de3c194e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_623f86ef-6cc9-45ce-b1a4-425b79ff621a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ae351fe7-dcf4-4d99-9dcd-b9b7de3c194e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_564c3993-3e7c-4683-afba-b831df18fc35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_623f86ef-6cc9-45ce-b1a4-425b79ff621a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_564c3993-3e7c-4683-afba-b831df18fc35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ba104124-4cba-4d86-904c-30e6a1f02920" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_623f86ef-6cc9-45ce-b1a4-425b79ff621a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ba104124-4cba-4d86-904c-30e6a1f02920" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cntb_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree_ff1ff921-b797-43c0-b028-e36efa341064" xlink:href="cntb-20250630.xsd#cntb_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_623f86ef-6cc9-45ce-b1a4-425b79ff621a" xlink:to="loc_cntb_LesseeOperatingLeaseLiabilityToBePaidAfterYearThree_ff1ff921-b797-43c0-b028-e36efa341064" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.connectbiopharm.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="cntb-20250630.xsd#LeasesScheduleofFutureMinimumLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.connectbiopharm.com/role/LeasesScheduleofFutureMinimumLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e9c5ab63-f77d-498a-82b4-7b1e119dc281" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f7a13596-af23-49f7-81c8-2c1e5c914cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e9c5ab63-f77d-498a-82b4-7b1e119dc281" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f7a13596-af23-49f7-81c8-2c1e5c914cb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_debd9024-d280-47e4-9cfc-682295947b94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e9c5ab63-f77d-498a-82b4-7b1e119dc281" xlink:to="loc_us-gaap_OperatingLeaseLiability_debd9024-d280-47e4-9cfc-682295947b94" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.connectbiopharm.com/role/SegmentReportingScheduleofReconciliationofSegmentNetLossDetails" xlink:type="simple" xlink:href="cntb-20250630.xsd#SegmentReportingScheduleofReconciliationofSegmentNetLossDetails"/>
  <link:calculationLink xlink:role="http://www.connectbiopharm.com/role/SegmentReportingScheduleofReconciliationofSegmentNetLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1e6c074e-4afb-46b1-b27e-a72d54e41773" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d4bba544-03a0-460e-b2dc-b8829e8da399" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1e6c074e-4afb-46b1-b27e-a72d54e41773" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d4bba544-03a0-460e-b2dc-b8829e8da399" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_cad21142-e2a4-4fd3-a8de-809855b92b64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1e6c074e-4afb-46b1-b27e-a72d54e41773" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_cad21142-e2a4-4fd3-a8de-809855b92b64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_0ac8f861-d8da-47e2-84f4-7d716a81cfba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1e6c074e-4afb-46b1-b27e-a72d54e41773" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_0ac8f861-d8da-47e2-84f4-7d716a81cfba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b923a967-1a3a-4f45-9e58-d952d07bfc00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1e6c074e-4afb-46b1-b27e-a72d54e41773" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_b923a967-1a3a-4f45-9e58-d952d07bfc00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_68ec42b9-6b45-4fc0-8e7e-766a738a94d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1e6c074e-4afb-46b1-b27e-a72d54e41773" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_68ec42b9-6b45-4fc0-8e7e-766a738a94d7" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
